Literature DB >> 18442179

The biology of chronic foot ulcers in persons with diabetes.

R Gary Sibbald1, Kevin Y Woo.   

Abstract

Diabetic foot ulcers constitute a major health problem and they are recalcitrant to healing due to a constellation of intrinsic and extrinsic factors. The purpose of this article is to review the potential biological mechanisms that deter healing and perpetuate inflammatory responses in chronic diabetes foot ulcers. The link between hyperglycemia induced oxidative stress and its negative impact on cellular functions are explained. Key evidence related to alteration in tissue perfusion, bacterial balance, sustained proteases and cytokines release, leukocyte function, and growth factor production at the local wound level are summarized.

Entities:  

Mesh:

Year:  2008        PMID: 18442179     DOI: 10.1002/dmrr.847

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  39 in total

Review 1.  Adenosine receptor agonists for promotion of dermal wound healing.

Authors:  María D Valls; Bruce N Cronstein; M Carmen Montesinos
Journal:  Biochem Pharmacol       Date:  2008-11-12       Impact factor: 5.858

Review 2.  A primer on wound healing in colorectal surgery in the age of bioprosthetic materials.

Authors:  Jonathan B Lundy
Journal:  Clin Colon Rectal Surg       Date:  2014-12

Review 3.  Diagnostics and treatment of the diabetic foot.

Authors:  Jan Apelqvist
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

4.  A retrospective study of diabetic foot ulcers treated with hyperbaric oxygen therapy.

Authors:  Alexandra J Bishop; Elizabeth Mudge
Journal:  Int Wound J       Date:  2012-02-28       Impact factor: 3.315

Review 5.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.

Authors:  Britta Kunkemoeller; Themis R Kyriakides
Journal:  Antioxid Redox Signal       Date:  2017-08-10       Impact factor: 8.401

6.  Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers.

Authors:  M Erdogan; S Solmaz; A Canataroglu; M Kulaksızoglu; S Cetinkalp; A G Ozgen; F Saygili; C Yilmaz
Journal:  Endocrine       Date:  2010-04-14       Impact factor: 3.633

7.  The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model.

Authors:  Joon Pio Hong; Sung Woo Park
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

8.  The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker.

Authors:  Gian Paolo Fadini; Mattia Albiero; Renato Millioni; Nicol Poncina; Mauro Rigato; Rachele Scotton; Federico Boscari; Enrico Brocco; Giorgio Arrigoni; Gianmarco Villano; Cristian Turato; Alessandra Biasiolo; Patrizia Pontisso; Angelo Avogaro
Journal:  Diabetologia       Date:  2014-06-25       Impact factor: 10.122

9.  Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.

Authors:  Mohan R Dasu; Ishwarlal Jialal
Journal:  J Diabetes Complications       Date:  2013-06-15       Impact factor: 2.852

10.  Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.

Authors:  Trung T Nguyen; Derong Ding; William R Wolter; Matthew M Champion; Dusan Hesek; Mijoon Lee; Rocio L Pérez; Valerie A Schroeder; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  Eur J Pharmacol       Date:  2018-07-19       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.